Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Tries Data Digitization To Speed Spontaneous Adverse Event Reporting

Executive Summary

Combining MedWatch capabilities with electronic medical records could change the face of spontaneous adverse event reporting, providing regulatory authorities with a larger volume of more timely reports

You may also be interested in...



PDR Network's AER Tool May Add Mechanism To Reimburse Physicians For Report Follow-ups

PDR Network, in conjunction with pharmaceutical manufacturers, is looking to add a feature on its new RxEvent adverse drug event reporting application that will compensate physicians for fielding follow-up calls about reports they’ve filed.

PDR Network's AER Tool May Add Mechanism To Reimburse Physicians For Report Follow-ups

PDR Network, in conjunction with pharmaceutical manufacturers, is looking to add a feature on its new RxEvent adverse drug event reporting application that will compensate physicians for fielding follow-up calls about reports they’ve filed.

Sentinel Will Benefit From Administration's Health IT Push - FDA's Hamburg

The Obama administration's emphasis on wiring health care comes at a key time for FDA's Sentinel postmarketing medical product safety monitoring project, agency Commissioner Margaret Hamburg pointed out at a Jan. 11 public workshop in Washington, D.C

Topics

UsernamePublicRestriction

Register

LL1134882

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel